p63 transcriptionally regulates the expression  of matrix metallopeptidase 13

Ivana Celardo; Alexey Antonov; Ivano Amelio; Margherita Annicchiarico-Petruzzelli; Gerry Melino

doi:10.18632/oncotarget.1778

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

p63 transcriptionally regulates the expression of matrix metallopeptidase 13

Ivana Celardo, Alexey Antonov, Ivano Amelio, Margherita Annicchiarico-Petruzzelli and Gerry Melino _

PDF | HTML | How to cite

Oncotarget. 2014; 5:1279-1289. https://doi.org/10.18632/oncotarget.1778

Metrics: PDF 2702 views | HTML 4691 views | ?

Abstract

Ivana Celardo1, Alexey Antonov1,2, Ivano Amelio1, Margherita Annicchiarico-Petruzzelli3 and Gerry Melino

1 Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK.

2 Saint-Petersburg State Institute of Technology, Saint- Petersburg, Russia.

3 Biochemistry Laboratory IDI-IRCC; Department of Experimental Medicine and Surgery; University of Rome “Tor Vergata”; Rome, Italy.

Correspondence:

Gerry Melino, email:

Keywords: p63, MMP13, Collagenase, skin, metastasis

Received: January 30, 2014 Accepted: February 12, 2014 Published: March 15, 2014

Abstract

p63 is a transcriptional factor belonging to p53 family of genes. Beside the role in cancer, partially shared with p53 and the other member p73, p63 also plays exclusive roles in development and homeostasis of ectodermal/epidermal-related organs. Here we show that p63 transcriptionally controls the expression of the matrix metallopeptidase 13 (MMP13). p63 binds a p53-like responsive element in the human promoter of MMP13, thus promoting the activation of its transcription. The catalytic activity of MMP13 is required in high invasion capacity of metastatic cancer cells, however, although p63 and MMP13 expression correlates in cancer patients, their co-expression does not predict cancer patient survival. Our results demonstrate that p63 directly controls MMP13 expression.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1778

Publication Alerts

Research Papers:

p63 transcriptionally regulates the expression of matrix metallopeptidase 13

Abstract